Https Immatics Com News Today

Investegate announcements from https://immatics.com/, Immatics Announces Third Quarter 2022 Financial Results and Business Update

Investegate announcements from https://immatics.com/, Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022

Investegate announcements from https://immatics.com/, Immatics Announces First Quarter 2022 Financial Results and Business Update

Investegate announcements from https://immatics.com/, Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs

Investegate announcements from https://immatics.com/, Immatics Announces Full Year 2021 Financial Results and Corporate Update

, 2021 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced changes to its Board of Directors. Christof Hettich, L.L.D., Managing Partner and founding member of the dievini Hopp BioTech holding GmbH & Co. KG, has decided to step down from Immatics’ Board of Directors. He has been a member of Immatics’ Board of Directors since 2006. Former Immatics Bo...

Immatics Presents Data Update on Dose Escalation from Ongoing ACTengine® Cell Therapy Programs   · cancer · Tumor shrinkage observed in 8 out of 10 patients including one partial response consistent with robust biological activity of infused T cell products · Houston, Texas and Tuebingen, Germany, March 17, 2021 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies,...